Skip to main content
. 2024 Nov 19;249:10361. doi: 10.3389/ebm.2024.10361

FIGURE 5.

FIGURE 5

Sphingolipids and lipid metabolism in RSD-mediated inflammation and cognitive impairment. (A) Cortex GSEA results of RSD exposure and minocycline-treated mice. (B) Mass spectrometry characterization of sphingolipid species found in the cortex. (C) Hippocampus GSEA results of RSD exposure and minocycline-treated mice. (D) Mass spectrometry characterization of sphingolipid species in the hippocampus.